Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Sinai Health System currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. This volume of activity indicates an active effort to secure patent protection for multiple innovations in the life sciences. By managing these active matters, the organization is pursuing a variety of technical claims within the Biotechnology & Pharmaceuticals sector.
The work is divided among 3 distinct examiners and 3 distinct art units, ensuring that each application is evaluated independently. This distribution across 3 distinct examiners means that the success of the portfolio is not dependent on an individual's interpretation of patent law. The involvement of 3 distinct art units further suggests that the inventions may cover different biological or pharmaceutical sub-specialties.
LU, FRANK WEI MIN is the busiest examiner, currently overseeing 1 busiest examiner pending action. Because LU, FRANK WEI MIN is responsible for 1 busiest examiner pending action, the remaining actions are handled by other examiners, necessitating a broad prosecution strategy. Practitioners should monitor the feedback from all examiners to identify the most effective ways to advance the 3 pending office actions.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LU, FRANK WEI MIN | 1 | 62.7% | +67.7% |
| WILSON, MICHAEL C | 1 | 41.5% | +17.9% |
| SITTON, JEHANNE SOUAYA | 1 | 53.2% | +48.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16760522 | CANCER DETECTION, CLASSIFICATION, PROGNOSTICATION, THERAPY PREDICTION AND THERAPY MONITORING USING METHYLOME ANALYSIS | SITTON, JEHANNE SOUAYA | 34d |
| 17825784 | TOOLS AND METHODS FOR USING CELL DIVISION LOCI TO CONTROL PROLIFERATION OF CELLS | WILSON, MICHAEL C | 79d |
| 18059370 | METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAME | LU, FRANK WEI MIN | — |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| 1638 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18059370 | METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAME | LU, FRANK WEI MIN | 1683 | §102§103§112DP | Non-Final OA | — | Pending | Nov 28, 2022 |
| 17825784 | TOOLS AND METHODS FOR USING CELL DIVISION LOCI TO CONTROL PROLIFERATION OF CELLS | WILSON, MICHAEL C | 1638 | §103§112DPOther | Non-Final OA | 79d | Pending | May 26, 2022 |
| 16760522 | CANCER DETECTION, CLASSIFICATION, PROGNOSTICATION, THERAPY PREDICTION AND THERAPY MONITORING USING METHYLOME ANALYSIS | SITTON, JEHANNE SOUAYA | 1682 | §103 | Final Rejection | 34d | Pending | Apr 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial